ALZHEIMER DEMENTIA

This is an early safety study testing a new drug designed to stimulate the body's natural immune defenses in people with early Alzheimer's disease or mild cognitive impairment. The trial will enroll 39 participants to receive either the drug or a placebo at different dose levels …

This study is testing whether a weekly infusion of a natural hormone called Allopregnanolone can help repair brain structure and slow memory loss in people with mild Alzheimer's disease. About 100 participants will receive either the treatment or a placebo for six months, with br…

This study is testing whether a medication called levetiracetam, commonly used for seizures, can prevent epileptic seizures in adults with Down syndrome who also have Alzheimer's disease. Researchers also want to see if the drug can slow down the brain changes and memory loss lin…

This study is testing a blood test to see if it can help doctors find Alzheimer's disease earlier in people who are hospitalized for sudden confusion or memory problems. Researchers will enroll 30 hospitalized patients aged 60-90 who have no prior dementia diagnosis. The main goa…

This study is testing whether a two-part treatment can help reduce apathy, a common loss of motivation, in people with Alzheimer's disease. Researchers are combining a stimulant medication (methylphenidate) with a gentle, non-invasive brain stimulation technique. The goal is to s…